HomeRVPH • NASDAQ
add
Reviva Pharmaceuticals Holdings Inc
Previous close
$0.47
Day range
$0.42 - $0.46
Year range
$0.30 - $4.28
Market cap
20.82M USD
Avg Volume
3.57M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.54M | -17.47% |
Net income | -6.43M | 13.46% |
Net profit margin | — | — |
Earnings per share | -0.13 | 48.00% |
EBITDA | — | — |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.29M | -55.82% |
Total assets | 7.08M | -47.56% |
Total liabilities | 11.54M | -22.27% |
Total equity | -4.46M | — |
Shares outstanding | 46.74M | — |
Price to book | -4.68 | — |
Return on assets | -144.78% | — |
Return on capital | 1,102.56% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.43M | 13.46% |
Cash from operations | -8.19M | 30.12% |
Cash from investing | — | — |
Cash from financing | 7.27K | -97.81% |
Net change in cash | -8.19M | 28.15% |
Free cash flow | -5.79M | 34.08% |
About
Founded
2018
Headquarters
Website
Employees
14
